79 related articles for article (PubMed ID: 2838035)
1. Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes.
Lown JW
Anticancer Drug Des; 1988 Jun; 3(1):25-40. PubMed ID: 2838035
[TBL] [Abstract][Full Text] [Related]
2. Molecular recognition between oligopeptides and nucleic acids: DNA sequence specificity and binding properties of thiazole-lexitropsins incorporating the concepts of base site acceptance and avoidance.
Rao KE; Shea RG; Yadagiri B; Lown JW
Anticancer Drug Des; 1990 Feb; 5(1):3-20. PubMed ID: 2156516
[TBL] [Abstract][Full Text] [Related]
3. DNA recognition by lexitropsins, minor groove binding agents.
Lown JW
J Mol Recognit; 1994 Jun; 7(2):79-88. PubMed ID: 7826677
[TBL] [Abstract][Full Text] [Related]
4. Progress in the design of DNA sequence-specific lexitropsins.
Walker WL; Kopka ML; Goodsell DS
Biopolymers; 1997; 44(4):323-34. PubMed ID: 9782774
[TBL] [Abstract][Full Text] [Related]
5. The binding of prototype lexitropsins to the minor groove of DNA: quantum chemical studies.
Mazurek P; Feng W; Shukla K; Sapse AM; Lown JW
J Biomol Struct Dyn; 1991 Oct; 9(2):299-313. PubMed ID: 1660279
[TBL] [Abstract][Full Text] [Related]
6. Control over the sequence specificity of DNA alkylation: syntheses and reactions with 32P-end-labelled DNA of N-alkyl-N-nitrosoureas linked to minor groove binding lexitropsins.
Gold B; Church KM; Wurdeman RL; Zhang Y; Chen FX
IARC Sci Publ; 1991; (105):439-42. PubMed ID: 1649793
[TBL] [Abstract][Full Text] [Related]
7. Molecular recognition between oligopeptides and nucleic acids: novel imidazole-containing oligopeptides related to netropsin that exhibit altered DNA sequence specificity.
Lown JW; Krowicki K; Bhat UG; Skorobogaty A; Ward B; Dabrowiak JC
Biochemistry; 1986 Nov; 25(23):7408-16. PubMed ID: 3026455
[TBL] [Abstract][Full Text] [Related]
8. Variation of DNA sequence specificity of DNA-oligopeptide binding ligands related to netropsin: imidazole-containing lexitropsins.
Burckhardt G; Luck G; Zimmer C; Störl J; Krowicki K; Lown JW
Biochim Biophys Acta; 1989 Sep; 1009(1):11-8. PubMed ID: 2551381
[TBL] [Abstract][Full Text] [Related]
9. DNA sequence-selective binding of head-to-tail linked bis-lexitropsins: relation of phasing to cytotoxic potency.
Guo D; Gupta R; Lown JW
Anticancer Drug Des; 1993 Oct; 8(5):369-97. PubMed ID: 8251044
[TBL] [Abstract][Full Text] [Related]
10. DNA minor groove binding of cross-linked lexitropsins: experimental conditions required to observe the covalently linked WPPW (groove wall-peptide-peptide-groove wall) motif.
Chen YH; Lown JW
Biophys J; 1995 May; 68(5):2041-8. PubMed ID: 7612846
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition between oligopeptides and nucleic acids. Monocationic imidazole lexitropsins that display enhanced GC sequence dependent DNA binding.
Kissinger K; Krowicki K; Dabrowiak JC; Lown JW
Biochemistry; 1987 Sep; 26(18):5590-5. PubMed ID: 2823885
[TBL] [Abstract][Full Text] [Related]
12. Computerized selection of potential DNA binding compounds.
Grootenhuis PD; Kollman PA; Seibel GL; DesJarlais RL; Kuntz ID
Anticancer Drug Des; 1990 Aug; 5(3):237-42. PubMed ID: 2169249
[TBL] [Abstract][Full Text] [Related]
13. Stacking interaction of guanine with netropsin in the minor groove of d(CGTATATACG)2.
Abrescia NG; Malinina L; Subirana JA
J Mol Biol; 1999 Dec; 294(3):657-66. PubMed ID: 10610787
[TBL] [Abstract][Full Text] [Related]
14. Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity.
Suzuki K; Nagasawa H; Uto Y; Sugimoto Y; Noguchi K; Wakida M; Wierzba K; Terada T; Asao T; Yamada Y; Kitazato K; Hori H
Bioorg Med Chem; 2005 Jun; 13(12):4014-21. PubMed ID: 15911314
[TBL] [Abstract][Full Text] [Related]
15. Ligands recognizing the minor groove of DNA: development and applications.
Wemmer DE
Biopolymers; 1999-2000; 52(4):197-211. PubMed ID: 11295751
[TBL] [Abstract][Full Text] [Related]
16. Short lexitropsin that recognizes the DNA minor groove at 5'-ACTAGT-3': understanding the role of isopropyl-thiazole.
Anthony NG; Johnston BF; Khalaf AI; MacKay SP; Parkinson JA; Suckling CJ; Waigh RD
J Am Chem Soc; 2004 Sep; 126(36):11338-49. PubMed ID: 15355117
[TBL] [Abstract][Full Text] [Related]
17. Molecular recognition between oligopeptides and nucleic acids: DNA binding selectivity of a series of 1,2,4-triazole-containing lexitropsins.
Rao KE; Krowicki K; Burckhardt G; Zimmer C; Lown JW
Chem Res Toxicol; 1991; 4(2):241-52. PubMed ID: 1664260
[TBL] [Abstract][Full Text] [Related]
18. A theoretical study of the sequence specificity in binding of lexitropsins to B-DNA.
Zakrzewska K; Lavery R; Pullman B
J Biomol Struct Dyn; 1987 Apr; 4(5):833-43. PubMed ID: 2855924
[TBL] [Abstract][Full Text] [Related]
19. Non-covalent ligand/DNA interactions: minor groove binding agents.
Nelson SM; Ferguson LR; Denny WA
Mutat Res; 2007 Oct; 623(1-2):24-40. PubMed ID: 17507044
[TBL] [Abstract][Full Text] [Related]
20. DNA-binding properties of nitroarene oligopeptides designed as hypoxia-selective agents.
Jenkins TC; Parrick J; Porssa M
Anticancer Drug Des; 1994 Dec; 9(6):477-93. PubMed ID: 7880374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
